Indeed, a recent study found that SARMs with potent growth-suppressive activity in prostate cancer activated the transcriptional activity of AR in a manner highly concordant to that of steroidal androgens, although effects on innate immune signaling were not reported in this study (99). The gene discussed is AR; the disease is prostate cancer.